Table 1. Phase II results with imatinib.... | American Society of Hematology

Table 1.

Phase II results with imatinib.

	Chronic Phase (IFN Failure)²²	Accelerated Phase²³	Blast Crisis²⁴
Abbreviations: IFN, interferon; CHR, complete hematologic response; MCR, major cytogenetic response (Ph⁺ metaphases < 35%); CCR, complete cytogenetic response.
CHR	95%	34%	8%
MCR	60%	24%	16%
CCR	41%	17%	7%
Disease progression	11%	40%	80%

	Chronic Phase (IFN Failure)²²	Accelerated Phase²³	Blast Crisis²⁴
Abbreviations: IFN, interferon; CHR, complete hematologic response; MCR, major cytogenetic response (Ph⁺ metaphases < 35%); CCR, complete cytogenetic response.
CHR	95%	34%	8%
MCR	60%	24%	16%
CCR	41%	17%	7%
Disease progression	11%	40%	80%